VTGNVistagen Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23500
Ticker: VTGN
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2009-07-01
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VTGN

Detail

Enriched 2026-08-14 20:47

Market cap: $11,591,249.15
Shares outstanding (class): 44,376,911
Shares outstanding (weighted): 44,376,911
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 41
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.vistagen.com
Description: Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Market cap and share counts drift.

Funds holding this security

7 funds · 7 positions · $1.12M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$663.2K	0.00%	1,160,455 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$236.5K	0.00%	413,745 NS	FIGI
AdvisorShares Psychedelics ETF AdvisorShares Trust	PSIL	$158.4K	0.78%	277,110 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$55.9K	0.00%	97,787 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$3.4K	0.00%	5,930 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$1.2K	0.00%	2,160 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$1.1K	0.00%	1,847 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVTGN
FIGI_COMPOSITEBBG000BB33L9
FIGI_SHARE_CLASSBBG001S67BH3
CIK0001411685
ISINUS92840H4002
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm per SIC 2834, so it maps to EQUITY | HEALTHCARE | PHARMACEUTICALS.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.